Skip to Content
Merck
  • Rasburicase for huge hepatocellular carcinoma with tumor lysis syndrome: case report.

Rasburicase for huge hepatocellular carcinoma with tumor lysis syndrome: case report.

Medical principles and practice : international journal of the Kuwait University, Health Science Centre (2012-06-13)
Chia-Ter Chao, Chih-Kang Chiang
ABSTRACT

To report a case of huge hepatocellular carcinoma associated with tumor lysis syndrome and its management. A 51-year-old hepatitis B carrier visited our clinic with progressive weight loss over recent months. Abdominal ultrasonography and magnetic resonance imaging revealed a huge hepatic mass in a cirrhotic liver, identified as hepatocellular carcinoma. A hepatologist and surgeon recommended transarterial chemoembolization followed by hepatectomy. The patient underwent the procedure, with the complication of tumor lysis syndrome. He was treated with a single high dose (9 mg) of rasburicase and his clinical condition improved dramatically, with acute kidney injury subsiding without emergent hemodialysis. This was a case of hepatocellular carcinoma with tumor lysis syndrome and acute kidney injury, treated successfully with rasburicase.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Uricase from Arthrobacter globiformis, lyophilized powder, 15-30 units/mg protein (biuret)
Sigma-Aldrich
Uricase from Bacillus fastidiosus, lyophilized, ~9 U/mg
Sigma-Aldrich
Uricase from Candida sp., recombinant, expressed in E. coli, lyophilized powder, ≥2 units/mg solid